SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
NATAN DAVID

(Last) (First) (Middle)
C/O PHARMANET DEVELOPMENT GROUP, INC.

(Street)
PRINCETON NJ 08540

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PharmaNet Development Group Inc [ PDGI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Restricted Stock Units, Par value $.001(1) 08/03/2007 A 894 A $26.91 18,887(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options to Purchase Common Stock, Par value $.001(3) $26.91 08/03/2007 A 1,678 08/03/2008 08/03/2014 Common Stock 1,678 $0 26,058(4) D
Restricted Stock Units, Par value $.001(5) $26.91 08/03/2007 A 894 (5) (5) Common Stock 894 $0 894(4) D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the 1999 Stock Plan.
2. This amount represents: (i) 13,015 restricted stock units granted pursuant to the 1999 Stock Plan which vest in 1/6 increments on each of June 30 and December 31, from the date of grant, subject to continued employment and tax withholding, and (ii) 894 restricted stock units granted pursuant to the 1999 Stock Plan which vest in 1/5 increments on each anniversary, from the date of grant, subject to continued employment and tax withholding, and (iii) 1000 shares of common stock, and (iv) 3,978 shares of restricted stock.
3. This amount represents options which were granted pursuant to the Company's 1999 Stock Plan which vest in 1/3 increments on each anniversary from the date of grant.
4. Such amount represents options which were granted pursuant to the Company's 1999 Stock Plan with different grant dates and different exercise prices.
5. Represents restricted stock units granted pursuant to the 1999 Stock Plan. Such restricted stock units shall vest only if PDGI meets or exceeds non-GAAP earnings per share target for 2007, 2008 and 2009.
/s/ David Natan 08/07/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.